002620 — Jeil Pharma Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapValue Trap

Market Cap
KR₩126bn
Enterprise Value
KR₩371bn
Revenue
KR₩780bn

Annual balance sheet for Jeil Pharma Holdings, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	29,961	47,224	53,403	59,131	75,883
Net Total Accounts Receivable
Net Total Receivables	175,601	165,490	178,157	194,297	202,528
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	335,074	335,144	352,916	384,527	409,561
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	170,479	212,965	233,120	228,862	243,942
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	887,395	892,421	865,677	879,997	890,433
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	327,317	298,024	358,505	412,636	377,991
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	479,943	480,691	527,912	560,536	583,483
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	407,452	411,731	337,765	319,461	306,950
Total Liabilities & Shareholders' Equity	887,395	892,421	865,677	879,997	890,433
Total Common Shares Outstanding